CLBS · Categories · Form 4
CLBS - SEC Form 4 insider transactions
Caladrius Biosciences Inc. (CLBS) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for CLBS
- SEC Form 4: Mazzo David J covered exercise/tax liability with 397 shares, decreasing direct ownership by 0.41% to 96,543 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Mazzo David J covered exercise/tax liability with 1,030 shares, decreasing direct ownership by 1% to 96,940 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Ruoslahti Erkki was granted 20,000 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Klosk Steven M was granted 20,000 shares, increasing direct ownership by 198% to 30,090 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Henson Heidi was granted 20,000 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Flowers Cynthia Louise was granted 20,000 shares, increasing direct ownership by 206% to 29,721 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Brown Gregory B was granted 20,000 shares, increasing direct ownership by 201% to 29,934 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Azab Mohammad was granted 20,000 shares, increasing direct ownership by 104% to 39,200 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Slack David W. was granted 24,000 shares and covered exercise/tax liability with 3,358 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Mazzo David J was granted 60,000 shares and covered exercise/tax liability with 11,315 shares, increasing direct ownership by 99% to 97,970 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Buck Kristen K was granted 18,000 shares and covered exercise/tax liability with 2,659 shares, increasing direct ownership by 75% to 35,823 units4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Azab Mohammad was granted 19,200 shares4 - LISATA THERAPEUTICS, INC. (0000320017) (Issuer)
- SEC Form 4: Buck Kristen K was granted 58,000 shares and covered exercise/tax liability with 69,959 shares, decreasing direct ownership by 4% to 307,244 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Mazzo David J was granted 150,000 shares and covered exercise/tax liability with 69,742 shares, increasing direct ownership by 12% to 739,444 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Mazzo David J covered exercise/tax liability with 13,082 shares, decreasing direct ownership by 2% to 631,065 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Girolamo Todd C covered exercise/tax liability with 4,721 shares, decreasing direct ownership by 3% to 160,827 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Mazzo David J was granted 401,000 shares and covered exercise/tax liability with 73,150 shares, increasing direct ownership by 104% to 644,147 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Girolamo Todd C was granted 129,000 shares and covered exercise/tax liability with 22,127 shares, increasing direct ownership by 182% to 165,548 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Buck Kristen K was granted 64,500 shares and covered exercise/tax liability with 7,694 shares, increasing direct ownership by 22% to 319,203 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Whitaker Anne Clem was granted 65,430 shares, increasing direct ownership by 56% to 182,635 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Traber Peter G was granted 65,430 shares, increasing direct ownership by 78% to 149,190 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Myers Steven S was granted 65,430 shares, increasing direct ownership by 45% to 212,269 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Klosk Steven M was granted 65,430 shares, increasing direct ownership by 76% to 151,390 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Flowers Cynthia Louise was granted 65,430 shares, increasing direct ownership by 81% to 145,847 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Davidson Michael H. was granted 65,430 shares, increasing direct ownership by 45% to 209,753 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Brown Gregory B was granted 65,430 shares, increasing direct ownership by 78% to 149,040 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Myers Steven S bought $30,190 worth of shares (33,785 units at $0.89), increasing direct ownership by 30% to 146,839 units4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)
- SEC Form 4: Buck Kristen K was granted 312,500 units of Common Stock and covered exercise/tax liability with 50,103 units of Common Stock4 - CALADRIUS BIOSCIENCES, INC. (0000320017) (Issuer)